Skip to main content
Erschienen in: International Urology and Nephrology 12/2020

26.08.2020 | Nephrology - Original Paper

Decreased insulin-like growth factor-1 (IGF-1) concentration correlates with reduced left-ventricle ejection fraction (LVEF) in hemodialysis patients

verfasst von: Vladimir Prelevic, Tanja Antunovic, Danilo Radunovic, Najdana Gligorovic Barhanovic, Branka Gledovic, Nebojsa Bulatovic, Marina Ratkovic, Nikolina Basic-Jukic

Erschienen in: International Urology and Nephrology | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The main purpose of this study is to determine the correlation between the serum IGF-1 concentration and certain cardiac indexes in hemodialysis patients.

Methods

The study was conducted at the Clinical Center of Montenegro and three regional hemodialysis centers. The echocardiographic studies were performed the day after the hemodialysis sessions. Blood samples were taken before dialysis for the measurement of IGF1 and PTH.

Results

A total of 102 patients were divided into two groups according to their left-ventricular ejection fraction (EF). Patients in the group with the higher EF had higher IGF-1 concentration (p = 0.024). IGF-1 was positively correlated with EF (ρ = 0.251, p = 0.012), and negatively correlated with LVMI (ρ = − 0.621, p < 0.001), SW (ρ = − 0.632, p < 0.001), and LW (ρ = − 0.632, p < 0.001). Multiple linear regression analysis was performed to determine the possible independent association between the EF and IGF-1 and the clinical data. The age of patients, their gender, and smoking habits did not have any combined influence on EF, but IGF-1 had a strong influence and was independently associated with the ejection fraction.

Conclusion

Our results may indicate the possible protective role of IGF-1 in the maintenance of heart structure and function in hemodialysis patients.
Literatur
1.
Zurück zum Zitat Alani H et al (2014) Cardiovascular co-morbidity in chronic kidney disease: current knowledge and future research needs. World J Nephrol 3(4):156–168CrossRef Alani H et al (2014) Cardiovascular co-morbidity in chronic kidney disease: current knowledge and future research needs. World J Nephrol 3(4):156–168CrossRef
2.
Zurück zum Zitat Borges MCC et al (2017) Malnutrition Inflammation Score cut-off predicting mortality in maintenance hemodialysis patients. Clin Nutr 17(4):63–67 Borges MCC et al (2017) Malnutrition Inflammation Score cut-off predicting mortality in maintenance hemodialysis patients. Clin Nutr 17(4):63–67
3.
Zurück zum Zitat Sun J et al (2016) Biomarkers and cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am SocNephrol 11(9):1163–1172CrossRef Sun J et al (2016) Biomarkers and cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am SocNephrol 11(9):1163–1172CrossRef
4.
Zurück zum Zitat Sood MM et al (2008) Left ventricular dysfunction in hemodialysis population. NDT Plus 4(6):199–205 Sood MM et al (2008) Left ventricular dysfunction in hemodialysis population. NDT Plus 4(6):199–205
5.
Zurück zum Zitat Momeni A et al (2016) Reduction of left ventricular ejection fraction after a 12-month follow-up in hemodialysis patients. J Ren Inj Prev 5(1):8–11CrossRef Momeni A et al (2016) Reduction of left ventricular ejection fraction after a 12-month follow-up in hemodialysis patients. J Ren Inj Prev 5(1):8–11CrossRef
6.
Zurück zum Zitat Menon V, Gul A, Sarnak MJ (2005) Cardiovascular risk factors in chronic kidney disease. Kidney Int 68(5):1413–1418CrossRef Menon V, Gul A, Sarnak MJ (2005) Cardiovascular risk factors in chronic kidney disease. Kidney Int 68(5):1413–1418CrossRef
7.
Zurück zum Zitat Conti E et al (2004) Insulin like growth factor-1 as a vascular protective factor. Circulation 110(5):2260–2265CrossRef Conti E et al (2004) Insulin like growth factor-1 as a vascular protective factor. Circulation 110(5):2260–2265CrossRef
8.
Zurück zum Zitat Torella D, Rota M, Nurzynska D et al (2004) Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94(10):514–524CrossRef Torella D, Rota M, Nurzynska D et al (2004) Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res 94(10):514–524CrossRef
9.
Zurück zum Zitat Youngman O (2012) The insulin-like growth factor system in chronic kidney disease: pathophysiology and therapeutic opportunities. Kidney Res ClinPract 31(11):26–37 Youngman O (2012) The insulin-like growth factor system in chronic kidney disease: pathophysiology and therapeutic opportunities. Kidney Res ClinPract 31(11):26–37
10.
Zurück zum Zitat Burgers AMG et al (2011) IGF-I and mortality: a meta-analysis. J Clin Endocrinol Metab 96(9):2912–2920CrossRef Burgers AMG et al (2011) IGF-I and mortality: a meta-analysis. J Clin Endocrinol Metab 96(9):2912–2920CrossRef
11.
Zurück zum Zitat Kamenicky P et al (2014) Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev 35(47):234–281CrossRef Kamenicky P et al (2014) Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev 35(47):234–281CrossRef
12.
Zurück zum Zitat Andreassen M et al (2009) IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endoc 160(6):25–31CrossRef Andreassen M et al (2009) IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur J Endoc 160(6):25–31CrossRef
13.
Zurück zum Zitat Zand L, Kumar R (2016) Serum parathyroid hormone concentrations and clinical outcomes in ESRD: a call for targeted clinical trials. Semin Dial 29(3):184–188CrossRef Zand L, Kumar R (2016) Serum parathyroid hormone concentrations and clinical outcomes in ESRD: a call for targeted clinical trials. Semin Dial 29(3):184–188CrossRef
14.
Zurück zum Zitat Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Levey AS, Riella MC, Shlipak MG, Wang H, White CT, Winearls CG, Kidney disease: Improving global outcomes (KDIGO) CKD work group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150CrossRef Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Levey AS, Riella MC, Shlipak MG, Wang H, White CT, Winearls CG, Kidney disease: Improving global outcomes (KDIGO) CKD work group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3(1):1–150CrossRef
15.
Zurück zum Zitat Mitchell C et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of echocardiography. J Am Soc Echocardiogr 32(1):1–64CrossRef Mitchell C et al (2019) Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of echocardiography. J Am Soc Echocardiogr 32(1):1–64CrossRef
16.
Zurück zum Zitat Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200CrossRef Ponikowski P et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37:2129–2200CrossRef
17.
Zurück zum Zitat Jia T, Gama Axelsson T, Heimbürger O et al (2014) IGF1 and survival in ESRD. Clin J Am Soc Nephrol 9(7):120–127CrossRef Jia T, Gama Axelsson T, Heimbürger O et al (2014) IGF1 and survival in ESRD. Clin J Am Soc Nephrol 9(7):120–127CrossRef
18.
Zurück zum Zitat Nilsson E et al (2016) A cohort study of insulin-like growth factor 1 and mortality in hemodialysis patients. Clin Kidney J 9(4):148–152CrossRef Nilsson E et al (2016) A cohort study of insulin-like growth factor 1 and mortality in hemodialysis patients. Clin Kidney J 9(4):148–152CrossRef
19.
Zurück zum Zitat Bleyer AJ, Tell GS et al (2006) Characteristics of sudden death in hemodialysis patients. Kidney Int 69(5):2268–2273CrossRef Bleyer AJ, Tell GS et al (2006) Characteristics of sudden death in hemodialysis patients. Kidney Int 69(5):2268–2273CrossRef
21.
Zurück zum Zitat Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2004) Prognostic value of echocardiographic indicators of leftventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. 15(8):1029–1037CrossRef Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, Seminara G, Stancanelli B, Malatino LS (2004) Prognostic value of echocardiographic indicators of leftventricular systolic function in asymptomatic dialysis patients. J Am Soc Nephrol. 15(8):1029–1037CrossRef
22.
Zurück zum Zitat Ganda A, Weiner SD, Chudasama NL, Valeri AM, Jadoon A, Shimbo D et al (2012) Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction. Clin Nephrol 77(9):366–375CrossRef Ganda A, Weiner SD, Chudasama NL, Valeri AM, Jadoon A, Shimbo D et al (2012) Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction. Clin Nephrol 77(9):366–375CrossRef
23.
Zurück zum Zitat Ritz E, Bommer J (2009) Cardiovascular problems on hemodialysis: current deficits and potential improvement. Clin J Am Soc Nephrol 4(7):71–78CrossRef Ritz E, Bommer J (2009) Cardiovascular problems on hemodialysis: current deficits and potential improvement. Clin J Am Soc Nephrol 4(7):71–78CrossRef
24.
Zurück zum Zitat Adrian DS (2012) Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab 98(1):36 Adrian DS (2012) Exploring metabolic dysfunction in chronic kidney disease. Nutr Metab 98(1):36
25.
Zurück zum Zitat Abdulle AM, Gillett MP, Abouchacra S, Sabri SM, Rukhaimi MA, Obineche EN, Singh J (2007) Low IGF1 levels are associated with cardiovascular risk factors in haemodialysis patients. Mol Cell Biochem 302(6):195–201CrossRef Abdulle AM, Gillett MP, Abouchacra S, Sabri SM, Rukhaimi MA, Obineche EN, Singh J (2007) Low IGF1 levels are associated with cardiovascular risk factors in haemodialysis patients. Mol Cell Biochem 302(6):195–201CrossRef
26.
Zurück zum Zitat Rees L (2016) Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr Nephrol 31(14):1421–1435CrossRef Rees L (2016) Growth hormone therapy in children with CKD after more than two decades of practice. Pediatr Nephrol 31(14):1421–1435CrossRef
Metadaten
Titel
Decreased insulin-like growth factor-1 (IGF-1) concentration correlates with reduced left-ventricle ejection fraction (LVEF) in hemodialysis patients
verfasst von
Vladimir Prelevic
Tanja Antunovic
Danilo Radunovic
Najdana Gligorovic Barhanovic
Branka Gledovic
Nebojsa Bulatovic
Marina Ratkovic
Nikolina Basic-Jukic
Publikationsdatum
26.08.2020
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 12/2020
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02595-8

Weitere Artikel der Ausgabe 12/2020

International Urology and Nephrology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.